120 related articles for article (PubMed ID: 8756739)
41. Plasma antiplasmin activities in experimental lung insufficiency.
Aasen AO; Saugstad OD; Lium B; Guldvog I; Lyngaas K; Larsbraaten M; Amundsen E
Acta Chir Scand Suppl; 1980; 499():113-21. PubMed ID: 6935891
[TBL] [Abstract][Full Text] [Related]
42. [Components of the fibrinolytic system of Guerin's epithelioma].
Zurawski P; Zagórska M; Grygoruk M; Worowski K
Acta Haematol Pol; 1985; 16(3-4):151-7. PubMed ID: 3835771
[No Abstract] [Full Text] [Related]
43. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
Sokolovskaya LI; Slominskii AY; Volkov GL
Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of fibrinolytic system, especially that of alpha 2 plasmin inhibitor deficient patient.
Sakata Y
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1506-12. PubMed ID: 7342652
[No Abstract] [Full Text] [Related]
45. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
46. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
47. The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance.
Wang H; Karlsson A; Sjöström I; Wiman B
Biochim Biophys Acta; 2006 Nov; 1764(11):1730-4. PubMed ID: 17064970
[TBL] [Abstract][Full Text] [Related]
48. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
49. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
Biagini D; Filippucci E; Agnelli G; Pagliaricci S
Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
[TBL] [Abstract][Full Text] [Related]
50. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
51. Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate.
Agren A; Kolmert T; Wiman B; Schulman S
Thromb Res; 2007; 119(6):715-21. PubMed ID: 16905180
[TBL] [Abstract][Full Text] [Related]
52. [Fibrinolysis parameters: plasmin-alpha2 antiplasmin complexes (PAP) and D-dimers in acute coronary syndromes without ST segment elevation].
Grabarczyk E; Wodyńska T; Kotschy M
Pol Merkur Lekarski; 2004 Dec; 17(102):555-7. PubMed ID: 15771120
[TBL] [Abstract][Full Text] [Related]
53. Relationship of cardiac troponin T and procoagulant activity in unstable angina.
Giannitsis E; Bardorff MM; Schweikart S; Wiegand U; Kampmann M; Katus HA
Thromb Haemost; 2000 Feb; 83(2):224-8. PubMed ID: 10739377
[TBL] [Abstract][Full Text] [Related]
54. [Problems in measuring the activity of alpha 2-plasmin inhibitor in the urokinase therapy].
Moriyama H; Minami S; Okamoto K; Tsuchiya T; Tsuji K; Higashi T
Rinsho Byori; 1987 Apr; 35(4):465-7. PubMed ID: 3613164
[No Abstract] [Full Text] [Related]
55. Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Feinberg WM; Macy E; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Bovill EG
Thromb Haemost; 1999 Jul; 82(1):100-3. PubMed ID: 10456461
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
57. [Changes in fast antiplasmin (alpha-2-antiplasmin) activity of the plasma of thoracotomized patients].
Fridrich L; Tuchmann A; Endler T; Meryn S; Moritz E
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():742-4. PubMed ID: 6647325
[No Abstract] [Full Text] [Related]
58. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
Nilsson T; Sjöholm I; Wiman B
Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
[TBL] [Abstract][Full Text] [Related]
59. Clinical relevants of the membrane protective action of aprotinin on the intraoperative histamine liberation.
Harke H; Rahman S
Prog Clin Biol Res; 1989; 308():959-63. PubMed ID: 2476829
[No Abstract] [Full Text] [Related]
60. [The role of histidine-rich glycoprotein in the regulation mechanism of fibrinolysis in humans].
Lijnen HR
Verh K Acad Geneeskd Belg; 1982; 44(5-6):307-29. PubMed ID: 6223461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
